Evidence map›Paper›PMID 38084981›Full record

ArticleMicrobiology spectrum2024

Antifungal susceptibility profile and local epidemiological cut-off values of

Jinhan Yu, Xueqing Liu, Dawen Guo, Wenhang Yang, Xinfei Chen, Guiling Zou, Tong Wang, Shichao Pang, Ge Zhang, Jingjing Dong and 3 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Journal of fungi (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jinhan YuDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.ORCID 0000-0003-3807-2088
Xueqing LiuDepartment of Clinical Laboratory, Yongzhou Central Hospital , Yongzhou, China.
Dawen GuoDepartment of Microbiology, the First Affiliated Hospital, Harbin Medical University , Harbin, China.
Wenhang YangDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.
Xinfei ChenDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.
Guiling ZouDepartment of Microbiology, the Fourth Affiliated Hospital, Harbin Medical University , Harbin, China.
Tong WangDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.
Shichao PangDepartment of Clinical Laboratory, The Second Affiliated Hospital of Luohe Medical College , Luohe, China.
Ge ZhangDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.
Jingjing DongDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.
Yingchun XuDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.ORCID 0000-0002-7126-9459
Ying ZhaoDepartment of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences , Beijing, China.ORCID 0000-0002-7093-1121
National China Hospital Invasive Fungal Surveillance Network (CHIF-NET)

Funding

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2021-I2M-1-038National high level hospital clinical research funding 2022-PUMCH-C-052National Natural Science Foundation of China (NSFC) 82202592| Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) 7222125
6 · The paper itself

Abstract

importance

Indexed as

Antifungal AgentsYarrowiaCandidaChinaDrug Resistance, FungalMicrobial Sensitivity TestsAntifungal Agentsantifungal susceptibility testingazole cross-resistanceCandida lipolyticaepidemiological cut-off valueERG11minimum inhibitory concentrationYarrowia lipolytica

Identifiers

PMID38084981
PMCPMC10783140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.